eurofins genomics americas (Subsidiary)

Eurofins Genomics provides the fastest high-quality products and services in the genomics industry. - Synthetic DNA (oligonucleotides) with hundreds of modification options and record-setting turnaround time - Specialized long RNA oligos with a large variety of modifications available - Gene Synthesis for individual genes or complete libraries using codon optimization software - Sanger Sequencing with overnight results anywhere in the US. - Nanopore Sequencing for whole plasmids, amplicons, and bacterial genome samples. Same day results. Impeccable quality. As part of the Eurofins Scientific group, the clients of Eurofins Genomics enjoy the power of over 14,000 staff in around 180 laboratories across 35 countries. Eurofins Scientific is the world leader in food and bio/ pharma products testing. Many of its labs are found here in the US and throughout the Americas. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, pharma discovery services, and central laboratory services.

eurofins do brasil análises de alimentos e ambientais (Subsidiary)

A Eurofins Scientific é líder mundial em análises de alimentos, meio ambiente e fármacos, com forte atuação em agroscience, genômica e pesquisa farmacológica. Fundada em 1987, na França, o grupo conta com mais de 65 mil colaboradores e 950 laboratórios em 60 países, oferecendo mais de 200 mil métodos analíticos. No Brasil, sua história começou em 1992 com a Genescan, adquirida pela Eurofins em 2001. Desde então, a empresa segue em expansão no país e na América Latina, consolidando sua presença em diversas regiões e segmentos. Principais marcos do crescimento da Eurofins no Brasil e América Latina: 2001 :: Eurofins | Genescan (São Paulo/SP) – Escritório 2002 :: Eurofins | Genescan (Itu/SP) – Laboratório 2006 :: Eurofins do Brasil (Indaiatuba/SP) 2007 :: Eurofins do Brasil (Indaiatuba/SP) - Agroscience Services 2009 :: Eurofins | Innolab (Rio de Janeiro/RJ) - Eurofins | Ambiental 2012 :: Eurofins | ALAC (Garibaldi/RS) 2013 :: Eurofins | GCL - Santiago / CH 2013 :: Eurofins | GCL Capacita (Santiago / CH) 2014 :: Eurofins | Anatech (São Paulo/SP) - Eurofins | Ambiental 2014 :: Eurofins | IPEX (Rio de Janeiro/RJ) - Eurofins | Ambiental 2015 :: Eurofins do Brasil (Recife/PE) 2015 :: Eurofins | Argentina - Buenos Aires 2016 :: Eurofins | Special Tests - São Bernardo do Campo, SP  2016 :: Eurofins | Ambiental - Rio Claro, SP 2017 :: Eurofins | Uruguai – Montevideo 2018 :: Eurofins | Paraguai - Asunción 2018 :: Eurofins | Clinical 2018 :: Eurofins | Centro de Genomas 2020 :: Itapema Eurofins | Clinical 2023 :: Eurofins | Labor3 - São Paulo, SP 2023 :: Eurofins | Quasfar - Bogotá, Colômbia 2024 :: Eurofins | Labormar - Barranquilla, Colômbia

eurofins danmark - laboratorium (Subsidiary)

Vil du være med til at teste alt fra jord til bord? Så er Eurofins stedet for dig. Eurofins er nemlig førende inden for Testing For Life - hvilket betyder, at vi laver næsten alle former for analyser og ydelser til områderne miljø, DNA-analyser, fødevarer, foder, materialer og produkter samt pharma. Vores laboratorier i Danmark er beliggende i Vejen, Glostrup, Ishøj, Aabybro, Aarhus og Galten. I Danmark er vi mere end 1.100 kollegaer, og vi er altid på udkig efter talentfulde og højt motiverede medarbejdere. På denne side kan du blive klogere på. hvordan Eurofins er som arbejdsplads.

eurofins central laboratory (Subsidiary)

Eurofins Central Laboratory is a global organization committed to providing standardized, high-quality central laboratory services for all phases of clinical trials. We blend the technical scale and quality standards of a large organization with the agility and personalized attention of a specialized partner. With over 25 years of experience and four fully owned, harmonized laboratory facilities located in the US, Europe, Singapore, and China, we offer one of the most extensive laboratory testing portfolios in the biopharmaceutical industry. Our testing capabilities include integrated safety assessments, biomarker assay development and validation, exploratory and endpoint biomarker analysis, molecular testing, global flow cytometry, pathology services, and support for vaccine development. We provide high-quality, globally harmonized data and expert scientific advice to facilitate smoother clinical trial execution and achieve superior outcomes for our clients and patients alike.